Matrix metalloproteinase-1 decorated polymersomes, a surface-active extracellular matrix therapeutic, potentiates collagen degradation and attenuates early liver fibrosis - ScienceDirect
Vaccination-based immunotherapy to target profibrotic cells in liver and lung - ScienceDirect
Collagen 1 Polyclonal Antibody – Bioss
Role of α1 and α2 chains of type IV collagen in early fibrotic lesions of idiopathic interstitial pneumonias and migration of lung fibroblasts | Laboratory Investigation
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease - ScienceDirect
Collagen 1 Polyclonal Antibody – Bioss
Frontiers | Collagen Type I as a Ligand for Receptor-Mediated Signaling
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction | Journal of Medicinal Chemistry
Stage-dependent expression of fibrogenic markers in alcohol-related liver disease - ScienceDirect
Collagen I alpha 1 Antibody [Unconjugated] (AF6220): Novus Biologicals
Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver | Journal of Proteome Research
Collagen 1 Polyclonal Antibody – Bioss
The Effect of Cardiogenic Factors on Cardiac Mesenchymal Cell Anti- Fibrogenic Paracrine Signaling and Therapeutic Performance
Frontiers | Fibrocytes: A Critical Review and Practical Guide
Figure 1 from Molecular Serum Markers of Liver Fibrosis | Semantic Scholar
Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer - ScienceDirect
Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis | Nature Communications
Collagen biology and non‐invasive biomarkers of liver fibrosis - Karsdal - 2020 - Liver International - Wiley Online Library
Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis | Nature Communications